Research & Development
Infectious: Page 2
National hepatitis C elimination program represents an historic opportunity, according to White House
The Biden-Harris administration proposes a five-year program to expand screening, testing, treatment, and prevention of hepatitis C, focusing on high-risk populations.
March 14, 2023
Calibre Scientific acquires AlphaScience to expand product portfolio, customer reach
AlphaScience will be integrated with Biozol Diagnostica, a subsidiary of Calibre Scientific, expanding its sales capabilities and product range for customers in the DACH region that comprises Germany, Austria, and Switzerland.
March 13, 2023
Electronic health record interventions reduce unnecessary urine culture orders, study finds
According to the study, electronic health record interventions can significantly reduce unnecessary urine culture orders, resulting in cost savings and improved patient care.
March 2, 2023
Laser light method identifies bacteria in fluids
An innovative way of shining a laser on a minute drop of blood, mucus, or wastewater enables the reflected light to identify the bacteria within.
March 3, 2023
Birmingham AIDS Outreach, Binx Health launch accessible HIV/STI testing program in Alabama
The program will serve the Birmingham, AL, metro area by providing access to self-collection kits for HIV and sexually transmitted infections (STIs) through a network of trusted partners that work with higher-risk populations.
March 1, 2023
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.
February 28, 2023
Chembio Diagnostics obtains FDA CLIA waiver for HIV-syphilis testing system
More than 200,000 CLIA-waived point-of-care testing sites in the U.S. can now use the system to detect HIV and syphilis, Richard Eberly, Chembio’s president and CEO, said in a statement.
February 24, 2023
Discovery of severe form of mpox spurs call for update to list of AIDS-defining diseases
Analyses of cases in earlier outbreaks of mpox, the viral disease formerly known as monkeypox, and of a small number of patients infected in the current multi-country outbreak suggested that people with advanced HIV may suffer more severe infections.
February 22, 2023
Becton Dickinson HPV assay FDA approved with BD SurePath, Hologic ThinPrep Pap tests
The BD Onclarity HPV Assay individually tests for an extended set of HPV types, including HPV 31, which poses a higher risk for causing cervical precancer than HPV 18, Becton Dickinson said.
February 21, 2023
Maternova, MedMira ink agreement to market rapid diagnostic tests for HIV, syphilis, hepatitis
MedMira's Multiplo TP/HIV rapid test delivers 100% sensitivity in identifying co-infections and is helping to reduce mother-to-child transmission of syphilis and HIV, the firms said.
February 21, 2023
Ingestible ‘smart pill’ may pinpoint GI disorders
An ingestible smart pill uses magnetic fields to track its movement through the GI tract, potentially facilitating the treatment of GI motility disorders.
February 13, 2023
Qiagen obtains CE Mark for tuberculosis blood test
Qiagen’s Ipsogen JAK2 RGQ PCR kit and NeuMoDx systems and reagents have already received CE Marks under the new IVDR requirements; the firm has pledged to transition all of its products to meet the new EU IVDR regulations.
February 15, 2023
Page 2 of 140